THE WORLD HEALTH ORGANIZATION (WHO) OFFICIALLY RECOMMENDED ON DECEMBER 14, 2017 THAT CANNABIS COMPOUND CANNABIDIOL (CBD) NOT BE INTERNATIONALLY SCHEDULED AS A CONTROLLED SUBSTANCE.
THE WORLD HEALTH ORGANIZATION (WHO) EXPERT COMMITTEE ON DRUG DEPENDENCE (ECDD) CONCLUDED THAT, "IN ITS PURE STATE, CANNABIDIOL (CBD) DOES NOT APPEAR TO HAVE ABUSE POTENTIAL OR CAUSE HARM."
THE WORLD HEALTH ORGANIZATION (WHO) DETERMINED THAT "CBD COULD BE USEFUL IN TREATING ALZHEIMER'S DISEASE, CANCER, PSYCHOSIS, PARKINSON'S DISEASE, AND OTHER SERIOUS CONDITIONS. IN FACT, IT IS CONSIDERED TO HAVE MANY HEALTH BENEFITS AND IS USED TO TREAT MANY HEALTH DIFFICULTIES INCLUDING STRESS, SLEEP DIFFICULTIES, ANXIETY, OTHER MENTAL HEALTH DIFFICULTIES, AND CHRONIC PAIN."
*These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure or prevent any disease.